rs117480926
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_006662.3(SRCAP):c.5705A>G(p.Glu1902Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0055 in 1,614,090 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1902Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_006662.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SRCAP | NM_006662.3 | c.5705A>G | p.Glu1902Gly | missense_variant | 26/34 | ENST00000262518.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SRCAP | ENST00000262518.9 | c.5705A>G | p.Glu1902Gly | missense_variant | 26/34 | 2 | NM_006662.3 | P1 | |
SRCAP | ENST00000411466.7 | c.5705A>G | p.Glu1902Gly | missense_variant | 26/34 | 3 | P1 | ||
SRCAP | ENST00000706321.1 | c.5705A>G | p.Glu1902Gly | missense_variant | 26/34 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00391 AC: 594AN: 152108Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00396 AC: 995AN: 251408Hom.: 5 AF XY: 0.00401 AC XY: 545AN XY: 135880
GnomAD4 exome AF: 0.00567 AC: 8282AN: 1461864Hom.: 39 Cov.: 31 AF XY: 0.00542 AC XY: 3943AN XY: 727230
GnomAD4 genome ? AF: 0.00390 AC: 594AN: 152226Hom.: 2 Cov.: 32 AF XY: 0.00391 AC XY: 291AN XY: 74416
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Apr 19, 2017 | BS1,BS2,BP6; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 19, 2015 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | SRCAP: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 30, 2024 | - - |
Floating-Harbor syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at